HYPMY Hypera S.A. — dividend yield, history & ex-dividend dates
Hypera S.A. is a prominent pharmaceutical enterprise primarily operating within Brazil. The company maintains a diverse product portfolio that includes a vast array of prescription medications, marketed under numerous brand names such as Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid. Beyond prescription drugs, Hypera S.A. also provides dermo-cosmetic solutions, notably through its Mantecorp Skincare line. Its consumer health segment features well-known brands including Apracur, Benegrip, Coristina d, Engov, Epocler, and Estomazil, among others. Furthermore, the company offers nutritional and vitamin supplements, with labels such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. Hypera S.A. is also a producer and distributor of a range of similar and generic medicines, including its Neo Química brand, as well as products identified by active ingredients like Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel. Initially known as Hypermarcas S.A., the company officially rebranded to Hypera S.A. in February 2018. Its corporate headquarters are located in São Paulo, Brazil.
Dividend Snapshot
Research Scores
Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.
Not Rated
How the Dividend Safety Score is built for HYPMY
| Input | Value | Points | Weight |
|---|---|---|---|
| Earnings payout ratio | Earnings payout ratio 53% (FY2025) | 88 | 20% |
| FCF payout ratio | FCF payout ratio 35% (FY2025) | 100 | 25% |
| Net debt / EBITDA | Net debt / EBITDA 3.4x (FY2025) | 50 | 15% |
| Interest coverage | Interest coverage 1.9x (FY2025) | 26 | 10% |
| Dividend record | 3 years of uninterrupted regular payments; last cut Apr 20, 2017 (-73.0%), within 10 years: capped at 50; suspension Mar 30, 2023, within 10 years: capped at 20 | 20 | 20% |
| Earnings stability | Net income positive in 5 of the last 5 fiscal years (FY2021–FY2025) | 100 | 10% |
Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.
How the Dividend Growth Score is built for HYPMY
| Input | Value | Points | Weight |
|---|---|---|---|
| 5-year dividend growth | 5-year dividend CAGR -0.4% (2020–2025) | 23 | 25% |
| Consecutive annual increases | 0 consecutive annual increases (through 2025) | 10 | 20% |
| Payout headroom | Headroom from the earnings payout ratio 53% (FY2025) | 81 | 20% |
| Earnings per share growth (3 years) | EPS CAGR -10.7% (FY2022–FY2025) | 0 | 15% |
| Revenue growth (3 years) | Revenue CAGR 0.7% (FY2022–FY2025) | 46 | 10% |
| 10-year dividend growth | N/A (not used) | N/A | 10% |
Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.
Key Metrics
Current Yield
5.07%
At the Oct 30, 2026 price
The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.Annualized Dividend
$0.2024
Declared Sep 25, 2026
The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.Frequency
Q Quarterly
How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.RSI (14)
33
As of Oct 30, 2026
Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.52-Week Range
$3.81 – $5.40
Closes through Oct 23, 2026
The lowest and highest price over the past year, showing where today's price sits in its recent range.Payout Ratio (TTM)
42.97%
12 months to Jun 30, 2026 (Q2 FY2026)
The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.Years Paying
15
How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.Price / Book (TTM)
1.33
Price as of Oct 25, 2026; latest reported book value
Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.S.A.F.E. Dividend Read
Quote & Key Data
Dividend Growth
Why the Yield Moved (90 Days)
HYPMY's dividend yield rose from 4.79% to 5.07% over the past ~90 days (+0.28 pp). Of that move, +0.01 pp came from changes in the dividend rate and +0.28 pp from the share price ($4.22 on Aug 03, 2026 → $3.99 on Oct 30, 2026). A yield that rises because the price fell is not an improvement in the payout itself.
Yield vs Its Own History
Across 272 daily observations over the past 13 months (through Oct 23, 2026), HYPMY's current yield is higher than approximately 79% of them. Our stored price history for HYPMY covers the past 13 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.
Adjusted Price History
Dividend History
Dividend Payment History
Ex-dividend calendar →| Amount | Type | Declared | Ex-Date | Record | Pay |
|---|---|---|---|---|---|
| $0.0506 Q | Regular | Sep 25, 2026 | Oct 05, 2026 | Oct 05, 2026 | N/A |
| $0.0505 Q | Regular | Jun 24, 2026 | Jul 06, 2026 | Jul 06, 2026 | N/A |
| $0.0501 M | Regular | Mar 27, 2026 | Apr 06, 2026 | Apr 06, 2026 | N/A |
| $0.0570 I | Special | N/A | Mar 02, 2026 | Mar 02, 2026 | Mar 09, 2026 |
| $0.0542 I | Regular | Dec 12, 2025 | Dec 30, 2025 | Dec 30, 2025 | N/A |
| $0.0551 Q | Regular | Sep 24, 2025 | Oct 06, 2025 | Oct 06, 2025 | N/A |
| $0.0532 I | Regular | Jun 18, 2025 | Jun 30, 2025 | Jun 30, 2025 | N/A |
| $0.0515 Q | Regular | Mar 25, 2025 | Apr 04, 2025 | Apr 04, 2025 | N/A |
| $0.0218 Q | Regular | Dec 30, 2024 | Jan 10, 2025 | Jan 09, 2025 | N/A |
| $0.0350 Q | Regular | Sep 24, 2024 | Oct 04, 2024 | Oct 04, 2024 | N/A |
| $0.0175 M | Special | Jul 22, 2024 | Aug 01, 2024 | Aug 01, 2024 | N/A |
| $0.0175 M | Regular | Jun 21, 2024 | Jul 01, 2024 | Jul 01, 2024 | N/A |
| $0.0175 I | Regular | May 21, 2024 | May 31, 2024 | May 31, 2024 | N/A |
| $0.0174 M | Regular | Apr 23, 2024 | May 02, 2024 | May 03, 2024 | N/A |
| $0.0174 M | Regular | Mar 15, 2024 | Mar 22, 2024 | Mar 25, 2024 | N/A |
| $0.0174 M | Regular | Feb 21, 2024 | Mar 01, 2024 | Mar 04, 2024 | N/A |
| $0.0174 S | Regular | Jan 30, 2024 | Feb 08, 2024 | Feb 09, 2024 | N/A |
| $0.0498 S | Regular | Dec 18, 2023 | Dec 28, 2023 | Dec 29, 2023 | N/A |
| $0.0498 S | Regular | Sep 26, 2023 | Oct 05, 2023 | Oct 06, 2023 | N/A |
| $0.0498 S | Regular | Jun 27, 2023 | Jul 06, 2023 | Jul 07, 2023 | N/A |
| $0.0573 S | Regular | Dec 20, 2022 | Dec 29, 2022 | Dec 30, 2022 | Jan 12, 2023 |
| $0.0573 S | Regular | Jun 23, 2022 | Jul 01, 2022 | Jul 05, 2022 | N/A |
| $0.0575 S | Regular | Mar 24, 2022 | Apr 01, 2022 | Apr 04, 2022 | N/A |
| $0.0542 S | Regular | N/A | Dec 31, 2021 | Jan 03, 2022 | Jan 18, 2022 |
| $0.0540 S | Regular | N/A | Oct 01, 2021 | Oct 04, 2021 | Jan 18, 2022 |
| $0.0541 S | Regular | Jul 06, 2021 | Jul 23, 2021 | Jul 26, 2021 | N/A |
| $0.0542 S | Regular | Mar 24, 2021 | Apr 01, 2021 | Apr 05, 2021 | N/A |
| $0.0544 S | Regular | Dec 22, 2020 | Dec 31, 2020 | Jan 04, 2021 | Jan 14, 2021 |
| $0.0545 S | Regular | N/A | Oct 26, 2020 | Oct 27, 2020 | Jan 14, 2021 |
| $0.0546 S | Regular | N/A | Jul 02, 2020 | Jul 06, 2020 | N/A |
| $0.0546 S | Regular | Mar 25, 2020 | Apr 03, 2020 | Apr 06, 2020 | N/A |
| $0.0747 Q | Regular | N/A | Dec 27, 2019 | Dec 30, 2019 | Jan 14, 2020 |
| $0.0627 Q | Regular | Sep 30, 2019 | Oct 09, 2019 | Oct 10, 2019 | Jan 14, 2020 |
| $0.0627 Q | Regular | N/A | Jul 05, 2019 | Jul 08, 2019 | Jan 14, 2020 |
| $0.0661 Q | Regular | Apr 02, 2019 | Apr 15, 2019 | Apr 16, 2019 | Feb 07, 2020 |
| $0.0902 Q | Regular | Dec 19, 2018 | Dec 28, 2018 | Dec 31, 2018 | Jan 16, 2019 |
| $0.0498 Q | Regular | Sep 28, 2018 | Oct 04, 2018 | Oct 08, 2018 | Jan 16, 2019 |
| $0.0532 Q | Regular | Jun 29, 2018 | Jul 06, 2018 | Jul 09, 2018 | Jan 16, 2019 |
| $0.0638 Q | Regular | Apr 03, 2018 | Apr 12, 2018 | Apr 13, 2018 | Jan 16, 2019 |
| $0.2827 Q | Regular | Dec 26, 2017 | Jan 04, 2018 | Jan 05, 2018 | Jan 17, 2018 |
| $0.3951 Q | Regular | Jun 21, 2017 | Jun 29, 2017 | Jul 03, 2017 | Jul 14, 2017 |
| $0.0160 I | Regular | Apr 04, 2017 | Apr 20, 2017 | Apr 24, 2017 | May 09, 2017 |
| $0.1932 S | Regular | Feb 10, 2017 | Feb 16, 2017 | Feb 21, 2017 | Mar 03, 2017 |
| $0.0789 Q | Regular | Jul 25, 2016 | Aug 03, 2016 | Aug 05, 2016 | Aug 22, 2016 |
| $0.0593 M | Regular | N/A | May 05, 2016 | May 09, 2016 | May 31, 2016 |
| $0.0806 I | One-off | N/A | May 02, 2013 | May 06, 2013 | May 17, 2013 |
| $0.0772 I | One-off | N/A | May 10, 2011 | May 12, 2011 | Jul 11, 2011 |
Peer Comparison
Selected Drug Manufacturers - Specialty & Generic dividend payers we cover, strongest DividendRank first — for context, not a recommendation.
| Ticker | Name | Yield | 5-Yr Growth | Streak | Rank |
|---|---|---|---|---|---|
| SGIOF | Shionogi & Co., Ltd. | 2.30% | 6.0% | 3 yrs | 78 |
| LVZPF | Livzon Pharmaceutical Group Inc. | 6.91% | 15.8% | 1 yr | 73 |
| NPNKF | Nippon Shinyaku Co., Ltd. | 3.34% | -0.7% | 0 yrs | 72 |
| RDY | Dr. Reddy's Laboratories Limited | 0.59% | 6.5% | 0 yrs | 68 |
Related Guides & Lists
HYPMY dividend — frequently asked questions
Does Hypera S.A. pay a dividend?
Yes. Hypera S.A. (HYPMY) currently pays a dividend. The annualized dividend is about $0.20 per share, a yield of approximately 5.07%.
What is Hypera S.A.'s dividend yield?
Hypera S.A.'s dividend yield is approximately 5.07%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.
How often does Hypera S.A. pay dividends?
Hypera S.A. pays dividends quarterly — 4 times per year.
How long has Hypera S.A. paid dividends?
Hypera S.A. has 15 years of dividend payments on record.
Data updated Oct 30, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.